JWJianming Wang

Jianming Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianming Wang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Lijun Wang

    Department of Ophthalmology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China

    5 shared publications
  • Hongsong Li

    Department of Ophthalmology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China

    3 shared publications
  • Lin Zhao

    Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China

    3 shared publications
  • Wenyi Zhang

    Department of Ophthalmology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

    3 shared publications
  • Yi Zhang

    Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China

    3 shared publications
  • Chao Sun

    Department of Ophthalmology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China

    2 shared publications

Latest Publications

  • Open Access

    Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition

    by Lijun Wang, Hongsong Li, Lei Xiong, Chao Sun, Jianming Wang

    Fibrosis after glaucoma drainage surgery (GDS) is the main factor behind glaucoma surgery failures. Previous studies showed that cereblon (CRBN) protein is involved in tissue differentiation, although its role in glaucoma remains unknown. Herein we explored the role of CRBN and its ligand thalidomide (THD) in fibrosis after GDS. Using a rat GDS model and TGF-β2-induced cell model, we investigated the functions of CRBN and THD. CRBN expression in Tenon capsule tissue was detected using immunofluorescence. Filtering bleb survival was monitored after surgery. Protein levels of α‑smooth muscle actin (SMA), fibronectin (FN), and proliferating cell nuclear antigen (PCNA) were measured by Western blotting and immunohistochemistry. Activation of the nuclear factor (NF)‑κB pathway was evaluated via detecting P65 and p‑P65 levels. CRBN expression was upregulated in Tenon capsule tissue after GDS. THD treatment significantly attenuated CRBN expression. Moreover, THD dose-dependently inhibited TGF-β2-induced cell proliferation. Western blotting confirmed that THD suppresses TGF-β2-induced transdifferentiation and proliferation of human Tenon fibroblasts. In vivo, topical THD application prolonged filtering bleb survival and restrained α-SMA expression. Mechanistically, THD inhibited P65 phosphorylation, thereby preventing the activation of the NF-κB pathway. CRBN is a key protein regulating fibrosis following GDS. THD exerts anti-fibrotic effects by targeting CRBN and inhibiting the NF-κB pathway. These findings unveil a novel intervention target, CRBN, for attenuating fibrogenesis after GDS.

  • Open Access

    Swept-Source OCT Angiography-Derived Regional Normative Data of Peripapillary Vessel Density in Healthy Populations

    by Zhuoyan Yang, Ruihua Jing, Yidan Wu, Jiaxin Gao, Shiyuan Hu, Jianming Wang

    The purpose of this study was to investigate the distribution of peripapillary vessel density (VD) across different regions of retinal and choroidal layers and analyze its influencing factors after axial length (AL) correction. This study included 337 eyes without significant fundus abnormalities or systemic conditions affecting blood flow. Swept-source optical coherence tomography angiography (SS-OCTA) was utilized to measure peripapillary VD and associated ocular parameters. VD in all regions of the choroidal layer decreased significantly with increasing AL among AL groups. In non-highly myopic eyes, VD followed the pattern temporal (T) > superior nasal (SN) > inferior nasal (IN) in the inner retina and superficial vascular complex (SVC), whereas in the deep vascular complex (DVC), it was inferior (I) > superior (S). In the choroid, VD ranked as nasal (N) > T. Highly myopic eyes showed higher temporal but lower nasal VD in the inner retina and SVC, whereas DVC exhibited the opposite trend. Choroidal VD decreased significantly across all regions, most prominently in the T hemisphere. Multivariable analysis identified age, signal strength, and retinal nerve fiber layer (RNFL) thickness as key determinants of inner retinal VD, whereas AL, signal strength, vertical cup-to-disc ratio (C/D), Bruch's membrane opening (BMO), and optic disc-fovea distance (DFD) significantly influenced choroidal VD. Inner retinal VD followed T > SN > IN, primarily contributed by the SVC, whereas choroidal VD followed N > T. With increasing AL, choroidal VD declined across all regions, most prominently in the T hemisphere, whereas the inner retinal VD trends varied by region and layer. The findings of this study may contribute to the early warning of the disease and provide an important theoretical basis for the study of myopia-related microcirculatory alteration mechanisms.

  • Open Access

    Fetuin-B Interacts With Insulin Receptor-β and Promotes Insulin Resistance in Retina Cells

    by Wenyi Zhang, Xin Wang, Shuwei Tian, Jianming Wang, Aiyi Zhou

    Purpose: The purpose of this study was to investigate the correlation between insulin and Fetuin-B (FETUB) and the influence of FETUB on insulin signaling pathway in diabetic retinopathy (DR). Methods: Enzyme-linked immunosorbent assay (ELISA) was used to analyze FETUB and insulin levels in the serum and aqueous fluid of patients with DR and healthy controls. Quantitative PCR (q-PCR), Western blotting, and ELISA were used to examine FETUB expression in ARPE-19, BV2, and Müller cells under insulin stimulation. Co-immunoprecipitation was used to investigate the interaction of FETUB with insulin receptor-β (IRβ). Insulin resistance (IR)-BV2 and IR-Müller cells were treated with FETUB recombinant protein or FETUB short hairpin RNA (shRNA) to explore the influence of FETUB on insulin signaling pathway in DR. LY294002 (a PI3K pathway inhibitor) was used to determine whether FETUB affects glucose metabolism via the PI3K/Akt pathway. Results: In aqueous fluid, FETUB concentrations were positively correlated with insulin levels. FETUB expression increased in Müller and BV2 cells under insulin regulation, and FETUB interacted with IRβ in retinal cells and mice retina. The interaction between IRβ and FETUB increased in BV2 and Müller cells under high-glucose than in controls. Insulin signaling pathway activation was suppressed in FETUB recombinant protein-treated BV2 and Müller cells but increased in FETUB shRNA-transfected cells. FETUB shRNA could not reverse LY294002-mediated inhibition of glucose transporter-4 expression. Conclusions: Retinal cells are the source of insulin-regulated FETUB. The FETUB interacts with IRβ and affects insulin signaling pathway in BV2 and Müller cells. FETUB may aggravate IR in BV2 and Müller cells via the PI3K/Akt pathway.


  • Open Access

    Pirfenidone Attenuates the EMT Process and the Secretion of VEGF in TGF‐β2‐Induced ARPE‐19 Cells via Inhibiting the Activation of the NF‐κB/Snail Signaling Pathway

    by Hongsong Li, Lijun Wang, Meilin Shao, Meimei Ren, Wenyi Zhang, Jian Zhou, Jianming Wang

    Aim. Pirfenidone (PFD), an antifibrotic drug, has various beneficial functions such as antioxidant, antifibrotic, and anti‐inflammatory effects. This study aimed to explore the molecular mechanisms underlying how PFD modulates retinal pigment epithelial (RPE) cells involved in neovascularization and subretinal fibrosis. Methods. ARPE‐19 cell lines were treated with transforming growth factor‐beta 2 (TGF‐β2) alone or in combination with PFD. RPE cell viability, as a consequence of PFD use, was determined by the CCK‐8 assay. Cell migration was assessed by the wound closure assay and quantified by the Image J software. Protein expression of the following markers was measured by the western blot analysis: an epithelial cell marker and E‐cadherin; mesenchymal cell markers, fibronectin, matrix metalloprotein‐9 (MMP‐9), and alpha‐smooth muscle actin (α‐SMA); a fibrotic marker and connective tissue growth factor (CTGF); an angiogenesis marker and vascular endothelial growth factor (VEGF); NF‐κB/Snail. The mRNA levels of fibronectin and α‐SMA were determined by quantitative real‐time PCR. VEGF was quantitatively measured by the enzyme‐linked immunosorbent assay. Results. The cell viability assay revealed that PFD had no significant cytotoxic effect on RPE cells at concentrations of less than 1 mg/mL. The cell scratch assay showed that TGF‐β2 stimulation significantly improved the migration of RPE cells and that PFD attenuated this effect. PFD significantly inhibited the TGF‐β2‐induced protein expression of E‐cadherin and increased the TGF‐β2‐induced protein expression of fibronectin, MMP‐9, α‐SMA, CTGF, and VEGF in ARPE‐19 cells. The mRNA expression of fibronectin and α‐SMA was inhibited by PFD in TGF‐β2‐inducedARPE‐19 cells. Additionally, the increased intracellular and supernatant expression of VEGF protein was suppressed by PFD. Mechanistically, RPE cells treated with PFD + TGF‐β2 exhibited a decrease in phosphorylation of the NF‐κB P65 subunit and activation of Snail, compared with the RPE cells treated with TGF‐β2 alone. Conclusion. PFD ameliorated TGF‐β2‐induced neovascularization and fibrosis by suppressing the NF‐κB/Snail signaling pathway. Therefore, PFD may be a potential drug in the treatment of age‐related macular degeneration.


  • Proanthocyanidins attenuate the high glucose‐induced damage of retinal pigment epithelial cells by attenuating oxidative stress and inhibiting activation of the NLRP3 inflammasome

    by Hongsong Li, Rong Li, Lijun Wang, Dingying Liao, Wenyi Zhang, Jianming Wang

    Diabetic retinopathy (DR) is a common diabetic complication known to cause vision impairment and blindness. Previous studies have demonstrated that proanthocyanidins (PACs), polyphenols that are naturally found in several plants and fruits, have powerful antioxidant and anti‐inflammatory effects on various cells. However, the effects and underlying mechanism of PACs against DR pathogenesis remain unknown. Here, we investigated the proliferation, apoptosis, and mechanisms of ARPE‐19 cells in response to oxidative stress and inflammation under high‐glucose conditions with or without PACs treatment. The Cell‐Counting Kit‐8 assay and western blot analysis showed that treatment with 10 μl PACs significantly increased cell proliferation and the expression level of Bcl‐2 in ARPE‐19 cells under high‐glucose conditions. Moreover, PACs attenuated the high glucose‐induced apoptosis, and the increased expression levels of caspase‐3 and Bax. Under high‐glucose conditions, the generation of reactive oxygen species (ROS) and levels of malondialdehyde increased, whereas the superoxide dismutase content decreased. Moreover, the expression level of the NLRP3 inflammasome, and the release of interleukin 1β (IL‐1β) and IL‐18 increased. PACs reversed all of these high glucose‐induced effects on ARPE‐19 cells. Additionally, exposure to nigericin sodium salt, an agonist of the NLRP3 inflammasome, upregulated expression of the NLRP3 inflammasome accompanied by the release of IL‐1β and IL‐18. Again, treatment with PACs markedly downregulated these effects. Collectively, these results demonstrate that PACs can prevent retinal pigment epithelial cells from high glucose‐induced injury via inhibiting the generation of ROS and activation of the NLRP3 inflammasome, suggesting PACs as a potential candidate for the management of DR.


  • Open Access

    Outer Plexiform Layer Angle: A Prognostic Factor for Idiopathic Macular Pucker Surgery

    by Ding-Ying Liao, Jorn-Hon Liu, Yu-Ping Zheng, Jian-Ming Wang, Hsiao-Ming Chao

    Purpose. To investigate the efficacy of idiopathic macular pucker (epimacular membrane) surgery and to identify the possible prognostic factor. Methods. This was a retrospective study which enrolled 38 patients with idiopathic macular pucker who underwent 23-gauge pars plana vitrectomy (PPV) with indocyanine green-assisted peeling of epiretinal membrane (ERM) and internal limiting membrane (ILM). Visual outcomes were assessed at the baseline and during the follow-up including best-corrected visual acuity (BCVA) and metamorphopsia score, as well as outer plexiform layer (OPL) angle and central retinal thickness (CRT) using spectral-domain optical coherence tomography (SD-OCT). A comparison was made between patients with the prepeeling CRTs ≥500 μm and those μm. A comparison was also made between patients with the prepeeling OPL angles ≥130° and those Results. Mean follow-up was 36.07 ± 4.62 months (range 1.30–96.70 months). BCVA was significantly improved from 0.26 ± 0.03 to 0.67 ± 0.04 ; metamorphopsia score was significantly reduced from 1.42 ± 0.16 to 0.61 ± 0.08 ; CRT was significantly decreased from 519.62 ± 13.41 μm to 385.37 ± 8.97 μm . Greater prepeeling OPL angle (≥130°) was associated with significantly greater BCVA improvement (Snellen E/LogMAR: ) and greater metamorphopsia reduction , as compared to smaller OPL angle (μm) did not significantly differ from that relevant to the prepeeling greater CRT (≥500 μm; ). Endophthalmitis, retinal tear, or retinal detachment was not observed after peeling. Conclusion. Indocyanine green-assisted ERM/ILM peeling combined with small gauge vitrectomy is associated with significant visual acuity improvement and metamorphopsia reduction in patients with idiopathic macular pucker. Greater prepeeling OPL angle rather than CRT might act as a useful prognostic factor in predicting better final visual functional outcomes.


  • Open Access

    OCT proves that vitreomacular adhesion is significantly more likely to develop vision-threatening retinal complications than vitreomacular separation

    by Ding-Ying Liao, Jorn-Hon Liu, Yu-Ping Zheng, Huei-Wen Shiu, Jian-Ming Wang, Hsiao-Ming Chao

    Background: SD-OCT is becoming commonplace in everyday practice. Vitreomacular adhesions (VMAs) are being more routinely diagnosed. Predictive studies to the natural course of VMA are thus clinically significant. Spectral domain-optical coherence tomography (SD-OCT) was presently utilized to analyze the incidence of floaters, the complete vitreomacular separation or VMA, the VMA complication, the vitreomacular angle (VMAng), and the complication mechanism. Methods: Monthly SD-OCT was performed on patients with/without symptomatic floaters. OCT allowed VMA and vitreomacular separation to be compared. The incidence was assessed applying one-tailed Fisher’s exact tests. The VMAngs between the inner retina and posterior hyaloid were measured, and the complication mechanism was studied using OCT image. For macular hole (MH), pre- and/or post-operative best corrected visual acuities (BCVAs; LogMAR), refractions and photoreceptor conditions were also evaluated. Results: Totally, 124 eyes were included; there were 116 eyes with VMA and 8 eyes with vitreomacular separation. Considering the percentages over 124 eyes, floaters were present in 14.5% of enrolled eyes (=18/124), consisting of 12.9% of eyes with VMA (16/124) and 1.6% of eyes with vitreomacular separation (2/124). Moreover, there were twelve eyes (9.7%) with VMA-associated vision-threatening complications, including MH (n = 8; 6.5%), retinal detachment (RD; n = 2; 1.6%), vitreomacular traction (VMT; n = 1; 0.8%) and macular pucker (MP; n = 1; 0.8%). Eyes with initial VMA had a significantly greater possibility of complications than eyes with initial vitreomacular separation (p = 0.03). Among these eyes with MH (n = 8), the pre-operative BCVA (LogMAR) was 1.1 ± 0.5, which was insignificantly (p = 0.35) improved to 0.8 ± 0.7 post-operatively. The VMAng of VMA eyes with MHs was 24.2 ± 24.9° (n = 8). The critical VMAng was 13.3°. Conclusions: A minority of eyes with VMA or vitreomacular separation had floaters. Moreover, the use of SD-OCT could identify vision-threatening sequelae, namely MH, RD, MP and VMT, and this was significantly more frequent in eyes with VMA than in eyes with complete vitreomacular separation. Therefore, SD-OCT might be a useful way of identifying either identity, and evaluating VMA-associated complications. Whether VMA eyes with MH (n = 8) that have a VMAng greater than critical VMAng have a greater likelihood of tangential traction and subsequent MH needs further investigation.


  • Open Access

    Efficacy and safety of 0.0015% tafluprost versus 0.005% latanoprost in primary open angle glaucoma, ocular hypertension: a Meta-analysis

    by Xi-Ting Yang, Lin Zhao, Li-Jun Wang, Yi Zhang, Ding-Ying Liao, Jian-Ming Wang

    AIM: To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of tafluprost 0.0015% eye drops [benzalkonium chloride (BAK) 0.1 mg/mL] compared with that of latanoprost 0.005% eye drops (BAK 0.2 mg/mL) for primary open angle glaucoma (POAG) and ocular hypertension (OHT). METHODS: All the randomized controlled trials (RCTs) about treating POAG and OHT comparing tafluprost and latanoprost were collected by searching PubMed, Embase, Cochrane Library, CNKI and VIP. The outcomes of interest to evaluate the clinical efficacy and adverse effects included IOP and patient-related drop discomfort. RESULTS: Five RCTs involving 888 glaucoma patients were included. The results showed that, 1) at the end of the study, no statistically significant differences were observed in IOP reduction [standard mean difference (SMD) =0.48, 95%CI 0.07 to 0.88, P=0.085] between tafluprost and latanoprost; 2) No statistically significant differences were observed in adverse events of foreign-body sensation [relative risk (RR) =0.62, 95%CI 0.26 to 1.46, P=0.269], eye irritation (RR=1.16, 95%CI 0.49 to 2.75, P=0.744), eye pain (RR=2.000, 95%CI 0.949 to 4.216, P=0.07), iris hyper-pigmentation (RR=0.741, 95%CI 0.235 to 2.334, P=0.61), dry eye (RR=1.154, 95%CI 0.409 to 3.256, P=0.79) and eye pruritus (RR=1.600, 95%CI 0.536 to 4.774, P=0.4) between tafluprost and latanoprost. However, tafluprost showed more reported incidence of conjunctival hyperaemia than latanoprost (RR=2.11, 95%CI 1.24 to 3.59, P=0.006). CONCLUSION: Tafluprost 0.0015% eye drops (BAK 0.1 mg/mL) and latanoprost 0.005% eye drops (BAK 0.2 mg/mL) are comparable in lowering IOP for open angle glaucoma (OAG) and OHT. It does not differ in the incidence of foreign-body sensation, eye irritation, eye pain, iris hyper-pigmentation, dry eye and eye pruritus, but tafluprost shows less ocular tolerability because of more incidence of conjunctival hyperaemia.